Oprah’s flip on weight loss drugs is a sign of what’s to come for the ‘Ozempic trade’ in 2024
Oprah Winfrey has changed her mind on weight loss drugs and others have, too. What's ahead for the category in
Read MoreOprah Winfrey has changed her mind on weight loss drugs and others have, too. What's ahead for the category in
Read More2024 will be another big year for weight loss drugs, which soared in popularity despite hefty price tags, mixed insurance
Read MoreThe rise of Ozempic and a health conscious consumer has the alcohol industry on the defensive. Yet, there's still opportunity
Read MoreHere are the biggest calls on Wall Street on Source link
Read MoreThe CDC's move to increase availability of Beyfortus, a monoclonal antibody from Sanofi and AstraZeneca, comes as RSV cases rise
Read MoreUBS analysts have identified stocks that could surprise, both positively and negatively, when their earnings results are released in the
Read MoreLiz Truss, the Reaganomics enthusiast who lasted just 44 days as U.K. prime minister, staged a comeback on Monday, drawing
Read MoreJudge Michael Newman of the Southern District of Ohio issued a ruling denying a preliminary injunction sought by the Chamber of
Read MoreAstraZeneca, Bristol Myers Squibb and other drugmakers have filed at least eight lawsuits seeking to declare the Medicare price talks
Read More